Peripheral neuropathy Board decisions

The Board remanded the appeal for further development, including obtaining an adequate medical opinion on the nature and etiology of the Veteran's acquired psychiatric disorder and ulnar neuropathy.

The Board remands the claims for increased ratings and TDIU due to the need for a contemporaneous VA examination given the Veteran's contentions of worsening symptoms and the lapse in time since the last examinations.

The Board granted service connection for multiple myeloma with plasmacytoma on cervical spine and peripheral neuropathy of the bilateral upper extremities, as secondary to the Veteran's multiple myeloma.

The Board granted service connection for neurocognitive disorder and memory loss, residuals of Guillain-Barré Syndrome, as well as peripheral neuropathy in the right and left upper and lower extremities, and erectile dysfunction, all residuals of GBS. The evidence was at least in equipoise to support these findings.

The Board granted service connection for LLE and RLE neuropathy of the peroneal nerve, effective May 25, 2016, and a TDIU from May 25, 2016. It also granted DEA benefits and SMC based on loss of use of both feet from July 28, 2020.

The Board denied the veteran's claims for service connection for left and right lower extremity neuropathy as they were not shown to be related to his service or secondary to a service-connected disability.

The Board granted new and relevant evidence for the claims of entitlement to service connection for bilateral lower extremity neuropathy, bilateral upper extremity neuropathy, and right knee pain. The claims for a cervical spine disability, head injury, headaches, lumbar spine arthritis, and right hip arthritis were denied.

The Board granted service connection for tinnitus and remanded the remaining issues, including various psychiatric disorders, middle back injury, ankle disabilities, knee disabilities, neuropathies, hearing loss, and headaches.

The Board remands the claims for service connection for bilateral upper and lower extremity peripheral neuropathy due to a need for additional development, including obtaining addendum opinions.

The Board remands the claims for service connection for COPD and peripheral neuropathy of the bilateral upper and lower extremities, including as due to herbicide agent exposure, because the VA medical opinions are inadequate.

The Veteran was granted an initial disability rating of 30 percent for left forearm ankylosis prior to February 9, 2024, and separate ratings under diagnostic codes 5206 and 5207 were denied. The increased rating for any left forearm condition after February 9, 2024, was also denied.

The Board remands the claims for service connection for ulnar neuropathy of both forearms due to an inadequate VA examination and the need for a new SOC.

The Board denied higher ratings for type II diabetes mellitus with erectile dysfunction and diabetic neuropathy of the upper and lower extremities, but granted initial 20 percent ratings for diabetic neuropathy of the left and right lower extremity, femoral nerve. The case was also remanded for a TDIU claim.

The Board granted service connection for Parkinson's disease and bilateral upper and lower extremity peripheral neuropathy, finding that the Veteran's current conditions are related to his in-service toxic exposure risk activity.

The Board denied the Veteran's claims for a compensable rating for bilateral hearing loss and an increased rating for tinnitus, and remanded claims for service connection for peripheral neuropathy of the upper and lower extremities.

The Board granted a 100 percent rating for chronic renal disease with nephrolithiasis and hypertension from March 26, 2019, but no earlier.

The appeal for service connection for right and left lower extremity radiculopathy was withdrawn by the Veteran's authorized representative before a decision was made.

The Board granted service connection for bilateral lower extremity peripheral neuropathy, finding it is as likely as not due to military service exposure to herbicide agents.

The Board granted increased ratings for right and left lower extremity peripheral neuropathy, effective March 14, 2019, and a 10 percent rating for right and left hip limitation of extension, effective July 15, 2020. Other claims were denied.

The appeal was withdrawn by the Veteran, and therefore, no issues remain for appellate consideration.